CUSIP 603170101 · who reports it, how much, and how much it matters to them
37 of the 720 hedge fund managers we track reported shares of Mineralys Therapeutics, Inc. (Nasdaq: MLYS) on Form 13F for 30 June 2026. Between them they reported USD 570m. The largest position belongs to Ra Capital Management, at USD 208m. The manager with the most riding on it is Sphera Funds Management, where it is 5.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management1 fund on PPLI.com | USD 208m | 1.8% |
| 2 | Orbimed Advisors1 fund on PPLI.com | USD 57m | 1.1% |
| 3 | Armistice Capital1 fund on PPLI.com | USD 47m | 0.6% |
| 4 | Sphera Funds Management1 fund on PPLI.com | USD 40m | 5.2% |
| 5 | Polar Capital LLP26 funds on PPLI.com | USD 38m | 0.1% |
| 6 | Millennium Management6 funds on PPLI.com | USD 33m | 0.0% |
| 7 | Logos Global Management1 fund on PPLI.com | USD 28m | 1.2% |
| 8 | Tudor Investment Corporation10 funds on PPLI.com | USD 20m | 0.0% |
| 9 | Rock Springs Capital Management2 funds on PPLI.com | USD 13m | 0.6% |
| 10 | Citadel Advisors32 funds on PPLI.com | USD 13m | 0.0% |
| 11 | Renaissance Technologies13 funds on PPLI.com | USD 10m | 0.0% |
| 12 | D. E. Shaw & Co.15 funds on PPLI.com | USD 9.5m | 0.0% |
| 13 | Eversept Partners3 funds on PPLI.com | USD 8.4m | 0.4% |
| 14 | Suvretta Capital Management4 funds on PPLI.com | USD 4.7m | 0.1% |
| 15 | Two Sigma Investments35 funds on PPLI.com | USD 4.4m | 0.0% |
| 16 | Brevan Howard Capital Management39 funds on PPLI.com | USD 4.1m | 0.0% |
| 17 | Burkehill Global Management5 funds on PPLI.com | USD 4m | 0.1% |
| 18 | Boothbay Fund Management2 funds on PPLI.com | USD 4m | 0.1% |
| 19 | Artia Global Partners1 fund on PPLI.com | USD 3.7m | 0.7% |
| 20 | 22NW1 fund on PPLI.com | USD 3.1m | 2.9% |
| 21 | Exoduspoint Capital Management7 funds on PPLI.com | USD 2.7m | 0.0% |
| 22 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 2.6m | 0.0% |
| 23 | Squarepoint Ops7 funds on PPLI.com | USD 2.3m | 0.0% |
| 24 | HighVista Strategies27 funds on PPLI.com | USD 2.3m | 0.5% |
| 25 | PFM Health Sciences3 funds on PPLI.com | USD 1.7m | 0.1% |
| 26 | Dafna Capital Management6 funds on PPLI.com | USD 1.2m | 0.2% |
| 27 | Verition Fund Management3 funds on PPLI.com | USD 937,000 | 0.0% |
| 28 | Magnetar Financial93 funds on PPLI.com | USD 818,000 | 0.0% |
| 29 | Greenland Capital Management1 fund on PPLI.com | USD 809,000 | 0.1% |
| 30 | Marshall Wace LLP84 funds on PPLI.com | USD 486,000 | 0.0% |
| 31 | Capital Fund Management S.A.12 funds on PPLI.com | USD 428,000 | 0.0% |
| 32 | Persistent Asset Partners10 funds on PPLI.com | USD 389,000 | 0.1% |
| 33 | The Quarry1 fund on PPLI.com | USD 340,000 | 0.0% |
| 34 | Lion Point Capital1 fund on PPLI.com | USD 283,000 | 1.4% |
| 35 | Walleye Capital8 funds on PPLI.com | USD 271,000 | 0.0% |
| 36 | Capstone Investment Advisors25 funds on PPLI.com | USD 226,000 | 0.0% |
| 37 | Aquatic Capital Management3 funds on PPLI.com | USD 141,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Sphera Funds Management | USD 40m | 5.2% |
| 2 | 22NW | USD 3.1m | 2.9% |
| 3 | Ra Capital Management | USD 208m | 1.8% |
| 4 | Lion Point Capital | USD 283,000 | 1.4% |
| 5 | Logos Global Management | USD 28m | 1.2% |
| 6 | Orbimed Advisors | USD 57m | 1.1% |
| 7 | Artia Global Partners | USD 3.7m | 0.7% |
| 8 | Rock Springs Capital Management | USD 13m | 0.6% |
| 9 | Armistice Capital | USD 47m | 0.6% |
| 10 | HighVista Strategies | USD 2.3m | 0.5% |
Mineralys Therapeutics, Inc. trades under the symbol MLYS on the Nasdaq. Its CUSIP, the code used on Form 13F, is 603170101.
37 of the 720 hedge fund managers PPLI.com tracks reported Mineralys Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 208m), Orbimed Advisors (USD 57m), Armistice Capital (USD 47m), Sphera Funds Management (USD 40m) and Polar Capital LLP (USD 38m).
37 managers in our coverage reported it, and between them they run 520 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Sphera Funds Management, where the position was 5.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Mineralys Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.